Latest Asx News

Domain Holdings Australia Limited is set for acquisition by CoStar Group at $4.43 per share, a premium supported by the Domain Board, Independent Expert, and controlling shareholder Nine. The scheme awaits shareholder and court approval, with a meeting scheduled for August.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Aeris Resources has completed the drawdown of a $60 million Guarantee Facility from Washington H. Soul Pattinson, alongside an extension of its Term Facility, freeing up restricted cash and reinforcing its financial flexibility.

Health and Plant Protein Group Ltd (HPP) reveals ongoing confidential discussions on corporate opportunities and reaffirms plans to return surplus assets to shareholders.

Barton Gold Holdings has entered binding terms to acquire the Wudinna Gold Project in South Australia, adding 279,000 ounces of gold resources to its portfolio. The $15 million transaction, largely settled in shares and milestone payments, awaits Cobra Resources shareholder approval.

The Takeovers Panel has declared unacceptable circumstances in Emu NL’s recent shareholder meeting, citing a controversial share placement and proxy voting issues that clouded the election outcome and board control.

Tigers Realm Coal’s ongoing efforts to divest its Russian mining assets have hit a significant impasse amid geopolitical tensions, regulatory hurdles, and a stalled sale agreement, leaving the company suspended from ASX trading.

Mt Malcolm Mines has successfully completed a $1.04 million entitlement offer and raised an additional $200,000 through a placement, bolstering funds for its Western Australian gold projects.

AVJennings Limited has secured crucial approvals from Australian and New Zealand regulators for its proposed acquisition by PM Nominees C Pty Ltd, moving the deal closer to completion.

Optiscan Imaging Ltd has commenced a landmark clinical study at Royal Melbourne Hospital, testing its cutting-edge InVue® and InForm™ devices to improve breast cancer surgery precision. The study aims to generate critical data for US FDA approval and could redefine surgical oncology workflows.

Collins Foods Limited has confirmed its FY25 earnings aligned closely with market forecasts, addressing ASX concerns over potential surprises. The company highlighted positive margin outcomes and clarified the impact of a Netherlands impairment.

Advance ZincTek Limited reports a remarkable shift from loss to profit in FY25, driven by stronger US sales and operational efficiencies after closing Perth facilities.